Candel Therapeutics, Inc. (CADL)
NASDAQ·Healthcare·Biotechnology
$8.77
+0.23%
Mkt Cap $615.21M
Analyst Ratings
Buy
2
Hold
1
Sell
0
Price Target (4 analysts)
$23.33
Range $22.00 – $25.00
Implied Upside
+166.0%
Consensus $23.33 vs current $8.77
NASDAQ·Healthcare·Biotechnology
$8.77
+0.23%
Mkt Cap $615.21M
Buy
2
Hold
1
Sell
0
Price Target (4 analysts)
$23.33
Range $22.00 – $25.00
+166.0%
Consensus $23.33 vs current $8.77